Inhibition of psychostimulant-induced and nicotine-induced craving
CA 2304592 A1 · Owner: Rosen, Bruce R. · Inventors: Rosen, Bruce R.; Breiter, Hans C.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention provides methods for inhibiting psychostimulant-induced or nicotine-induced craving of additional psychostimulants (e.g. cocaine or amphetamine) or nicotine. In these methods D1-like (dopamine receptor) , antagonists or agonists selected from the group consisting of SCH-39166 SCH-, 23388, SCH-23390, A-69024, bulbocapnine (+)butaclamol HCI, fluphenazine HCI, cis-(Z)-flupenthixol fluspirilene, haloperidol, SCH-12679, SKF-83566 thioridazine HCI, thiothixene HCI, trifluoperazine 2HCI trifluperidol HCI, A-, 86929, skf-81297 SKF-38393, R(-)-N-allylnorapomorphine HBr R-(-)-apomorphine , HCI, R-(+)-6-bromo-APB R-(+)-6-chloro-ABP, (+)-SKF-82958, Pergolide methanesulfonate, and …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 24, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 24, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 24, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.